Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19302753 | 0.90 | KDM4E (0.55) | LMNARECQLALDH1A1HSD17B10 | |
| Rac-3-N-Butylphthalide SCHEMBL28830050 | 0.87 | MAOB (0.48) | LMNAALDH1A1HSD17B10 | |
| SCHEMBL19283540 | 0.82 | ALDH1A1 (0.49) | ALDH1A1HSD17B10 | |
| SCHEMBL29756436 | 0.82 | ALDH1A1 (0.49) | ALDH1A1HSD17B10 | |
| SCHEMBL27667860 | 0.81 | ALDH1A1 (0.48) | ALDH1A1HSD17B10 | |
| SCHEMBL9870428 | 0.80 | EDNRB (0.40) | EGFR | |
| SCHEMBL4899583 | 0.80 | APEX1 (0.69) | LMNARECQLALDH1A1HSD17B10 | |
| SCHEMBL21396055 | 0.79 | LMNA (0.53) | LMNARECQLALDH1A1HSD17B10 | |
| SCHEMBL4021498 | 0.79 | ALDH1A1 (0.47) | ALDH1A1HSD17B10 | |
| Rac-3-N-Butylphthalide SCHEMBL22551101 | 0.79 | MAOB (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11578049-B2 | Benzoic acid compound and method for preparing the same | HENAN GENUINE BIOTECH CO., LTD. (CN) | 2023-02-14 | — | — | US | disclosed |
| EP-3845524-A1 | BENZOIC ACID COMPOUNDS AND PREPARATION METHOD THEREFORE AND APPLICATIONS THEREOF | Henan Genuine Biotech Co., Ltd. (CN) | 2021-07-07 | — | — | EP | disclosed |
| US-20210002244-A1 | BENZOIC ACID COMPOUND AND METHOD FOR PREPARING THE SAME | HENAN GENUINE BIOTECH CO., LTD. (CN) | 2021-01-07 | — | — | US | disclosed |
| WO-2019179346-A1 | BENZOIC ACID COMPOUNDS AND PREPARATION METHOD THEREFORE AND APPLICATIONS THEREOF | 河南真实生物科技有限公司 | 2019-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11578049-B2 | Benzoic acid compound and method for preparing the same | GABBR2, GABRA1, GABRA6 | LMNA 493/4885RECQL 3523/4885ALDH1A1 1354/4885 |
| US-20210002244-A1 | BENZOIC ACID COMPOUND AND METHOD FOR PREPARING THE SAME | GABBR2, GABRA1, GABRA6 | LMNA 493/4885RECQL 3523/4885ALDH1A1 1354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.